☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EGFR-Mutated Lung Cancer
AstraZeneca's Tagrisso (osimertinib) Receives EU's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated L...
May 28, 2021
AstraZeneca's Tagrisso (osimertinib) Receives the US FDA's Approval for the Adjuvant Treatment of Patients with Early-Stage EGFR-M...
December 22, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.